Chimerix
Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases.

Year Established: 2000
Stock Ticker: CMRX
Exchange: NASDAQ